Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 7, 2007, Pages 1535-1536

  Lykouras, Lefteris ^a   Rizos, Emmanouil ^a   Gournellis, Rossetos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; MIRTAZAPINE; QUETIAPINE; VENLAFAXINE; ZIPRASIDONE;

ADULT; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; REPEATED DRUG DOSE; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MIDDLE AGED; PIPERAZINES; QUINOLONES;

EID: 34548126901     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.06.010     Document Type: Letter

References (12)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Text revision. Fourth Edition (2000), American Psychiatric Association, Washington, DC 805
2. 2 receptors. J Pharmacol Exp Ther 302 1 (2002) 381-389
3. Correll C.U., Leucht S., and Kane J.M. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161 (2004) 414-425
4. Duggal H.S. Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry 48 (2003) 771-772
5. Gupta S., and Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 16 3 (2004) 155-166
6. Lerer B., Segman R.H., Fangerau H., Daly A.K., Basile V.S., Cavallaro R., et al. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27 1 (2002) 105-119
7. Lieberman J.A. Aripiprazole. In: Schatzberg A.F., and Nemeroff C.B. (Eds). Textbook of psychopharmacology. 3rd ed (2004), American Psychiatric Publishing Inc, New York 487-494
8. Maytal G., Ostacher M., and Stern T.A. Aripiprazole related-tardive dyskinesia. CNS Spectr 11 6 (2006) 435-439
9. Nasrallah H.A. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Ann Clin Psychiatry 18 1 (2006) 57-62
10. Sharma A., Ramaswamy S., and Dewan V.K. Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiat 7 1 (2005) 36
11. Tarsy D., and Baldessarini R.J. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord 21 (2006) 589-598
12. Witschy J.K., and Winter J.K. Improvement in tardive dyskinesia with aripiprazole use. Can J Psychiatry 50 (2005) 188